| Revision as of 02:43, 24 June 2004 editGdvorsky (talk | contribs)209 editsNo edit summary← Previous edit | Revision as of 02:44, 24 June 2004 edit undoGdvorsky (talk | contribs)209 editsNo edit summaryNext edit → | ||
| Line 7: | Line 7: | ||
| ==Related articles== | ==Related articles== | ||
| * ]<br> | * ]<br> | ||
| * ]<br> | * ]<br> | ||
| * ] | * ] | ||
Revision as of 02:44, 24 June 2004
Aubrey de Grey (b. 1963) is a pioneering biogerontologist at the University of Cambridge in England who is currently working to expedite the development of a true cure for human aging, a medical goal he refers to as engineered negligible senescence. De Grey is also an outspoken supporter of radical life extension.
Prior to his work as a biologist, de Grey was formally trained in computer science—a discipline that provided him with insight into the human aging problem and cellular biology in particular. He argues that the fundamental knowledge necessary to develop effective anti-aging medicine mostly exists today. To that end he works to identity and promote specific technological approaches to the reversal of various aspects of aging and for the more proactive and urgent approaches to extending the healthy human lifespan.
De Grey's current work at Cambridge centers around a detailed plan called Strategies for Engineered Negligible Senescence (SENS) which is aimed at preventing age-related physical and cognitive decline. He is also the co-founder and chief scientist of the Methuselah Mouse Prize, a contest designed to accelerate research into effective life extension interventions by awarding prizes to researchers who extend the lifespan of mice to unprecedented lengths.